Elsevier

Journal of Nuclear Cardiology

Volume 10, Issue 5, September–October 2003, Pages 543-556
Journal of Nuclear Cardiology

Original Article
American society of nuclear cardiology practice guidelines: PET myocardial glucose metabolism and perfusion imaging

https://doi.org/10.1016/S1071-3581(03)00648-2Get rights and content

Section snippets

Introduction to the Guidelines

Cardiac positron emission tomography (PET) imaging is a well-validated, reimbursable means to assess myocardial perfusion, left ventricular function, and viability. Presently, there is a proliferation of PET instrumentation as well as an increase in educational programs that specifically address PET imaging. Technologists performing PET scans as well as physicians interpreting them should have a sound knowledge of recommended standards for the performance, interpretation, and quality control of

PET myocardial glucose metabolism and perfusion imaging: Part I – Guidelines for patient preparation and data acquisition

Stephen L. Bacharach, PhD, Jeroen J. Bax, MD, James Case, PhD, Dominique Delbeke, MD, Karen A. Kurdziel, MD, William H. Martin, MD, and Randolph E. Patterson, MD

First page preview

First page preview
Click to open first page preview

References (21)

There are more references available in the full text version of this article.

Cited by (93)

  • Myocardial Viability Testing by Positron Emission Tomography: Basic Concepts, Mini-Review of the Literature and Experience From a Tertiary PET Center

    2020, Seminars in Nuclear Medicine
    Citation Excerpt :

    This condition is emulated by most viability preparation protocols. In nondiabetic subjects, an oral glucose load (50 g of sugar solution) results in rapidly elevated levels of insulin and concomitantly suppressed levels of the quantitatively most important competing fuel, fatty acids.48 Insulin levels quite consistently peak after about 60 minutes,49 but the biological effects persist for at least another 30-60 minutes.

  • Myocardial perfusion imaging in coronary artery disease

    2015, Cor et Vasa
    Citation Excerpt :

    Such improvements include the ability to extract myocardial blood flow reserve and coronary flow reserve measurements [13]. PET has improved spatial resolution as 2–3 mm as compared with the 6- to 8-mm resolution of conventional SPECT imaging [14]. MPI PET has been extensively evaluated and has been shown to be both sensitive and specific for the diagnosis of CAD.

  • Dipeptidyl peptidase 4 inhibition increases myocardial glucose uptake in nonischemic cardiomyopathy

    2012, Journal of Cardiac Failure
    Citation Excerpt :

    18F-FDG-PET/computerized tomographic (CT) scans were performed before and after the treatment with sitagliptin. The patient preparation was performed in accordance with the American Society of Nuclear Cardiology Practice Guidelines for oral glucose loading.34 In short, patients fasted for ≥6 hours before arrival.

View all citing articles on Scopus

Publication supported by educational grants from Amersham Health, Inc, Bracco Diagnostics, Inc, Bristol-Meyers Squibb Medical Imaging, Inc, CardinalHealth Nuclear Pharmacy Services, Fujisawa Health Care, Inc, GE Medical Systems, Inc, MDS Nordion, Philips Medical Systems, Inc, Siemens Medical Systems, Inc, and Tyco Healthcare/Mallinckrodt.

Reprint requests: American Society of Nuclear Cardiology, 9111 Old Georgetown Rd, Bethesda, MD 20814, [email protected]

View full text